Odor Identification Deficit as a Predictor of Five-Year Global Cognitive Change: Interactive Effects with Age and ApoE-ε4

Olfactory impairments are present in common neurodegenerative disorders and predict conversion to dementia in non-demented individuals with cognitive impairment. In cognitively intact elderly, evidence is sparse regarding the role of olfactory deficits in predicting cognitive impairment. The present study investigated predictors of 5-year prospective decline in the Mini-Mental State Examination (MMSE) in a large (n = 501), population-based sample of elderly (65–90 years) individuals. All participants were genotyped for the ApoE gene, assessed for health factors, and were non-demented at the baseline assessment. After partialling out the influences of demographic and health-factors at baseline and dementia at follow-up, poor odor identification ability in combination with older age and the ApoE-ε4 allele predicted larger prospective global cognitive decline. This effect could not be produced by a vocabulary test. In sum, the findings suggest that an olfactory deficit can dissociate between benign and malign global cognitive development in non-demented, very old ε4-carriers, who are at high risk of developing dementia.

[1]  Jiang-Ning Zhou,et al.  Olfactory identification and apolipoprotein E ε4 allele in mild cognitive impairment , 2002, Brain Research.

[2]  D. Royall,et al.  Severe Dysosmia Is Specifically Associated with Alzheimer-Like Memory Deficits in Nondemented Elderly Retirees , 2002, Neuroepidemiology.

[3]  PhilipR. Wenham,et al.  Apolipoprotein E genotyping by one-stage PCR , 1991, The Lancet.

[4]  Catriona M. Morrison,et al.  ApoE gene and familial risk of Alzheimer's disease as predictors of odour identification in older adults , 2006, Neurobiology of Aging.

[5]  B. Angelin,et al.  Apolipoprotein E polymorphism in a healthy Swedish population: variation of allele frequency with age and relation to serum lipid concentrations. , 1993, Clinical chemistry.

[6]  E. Tulving,et al.  Episodic and semantic memory , 1972 .

[7]  E. Cochran,et al.  Apolipoprotein E ε4 allele, AD pathology, and the clinical expression of Alzheimer’s disease , 2003, Neurology.

[8]  Rajesh Pahwa,et al.  Age at onset in two common neurodegenerative diseases is genetically controlled. , 2002, American journal of human genetics.

[9]  Paul E. Gilbert,et al.  Differences between recognition memory and remote memory for olfactory and visual stimuli in nondemented elderly individuals genetically at risk for Alzheimer's disease , 2004, Experimental Gerontology.

[10]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[11]  D. Carmelli,et al.  Impaired Olfaction Predicts Cognitive Decline in Nondemented Older Adults , 2002, Neuroepidemiology.

[12]  D P Salmon,et al.  Very Early Changes in Olfactory Functioning Due to Alzheimer's Disease and the Role of Apolipoprotein E in Olfaction a , 1998, Annals of the New York Academy of Sciences.

[13]  Lars Bäckman,et al.  Apolipoprotein E and cognitive performance: a meta-analysis. , 2004, Psychology and aging.

[14]  L. Nyberg,et al.  The betula prospective cohort study: Memory, health, and aging , 1997 .

[15]  R. Struble,et al.  The distribution of apolipoprotein E in mouse olfactory epithelium , 2007, Brain Research.

[16]  P. Moberg,et al.  Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases. , 1998, Archives of neurology.

[17]  Lars Bäckman,et al.  Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis. , 2005, Neuropsychology.

[18]  B. Winblad,et al.  APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging , 2004, Neurology.

[19]  D. Bennett,et al.  Odor Identification and Decline in Different Cognitive Domains in Old Age , 2006, Neuroepidemiology.

[20]  L. Bäckman,et al.  Multiple cognitive deficits during the transition to Alzheimer's disease , 2004, Journal of internal medicine.

[21]  D. Bennett,et al.  Amyloid mediates the association of apolipoprotein E e4 allele to cognitive function in older people , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[22]  Lars Bäckman,et al.  Influences of preclinical dementia and impending death on the magnitude of age-related cognitive deficits. , 2002, Psychology and aging.

[23]  Lars-Göran Nilsson,et al.  Demographic and cognitive predictors of cued odor identification: evidence from a population-based study. , 2004, Chemical senses.

[24]  K. Davis,et al.  Olfactory identification deficits in relatives of Alzheimer's disease patients , 1996, Biological Psychiatry.

[25]  D A Bennett,et al.  The relationship between cerebral Alzheimer’s disease pathology and odour identification in old age , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[26]  K. Marder,et al.  Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up. , 2000, The American journal of psychiatry.

[27]  C. Hawkes.  Olfaction in neurodegenerative disorder , 2003, Movement disorders : official journal of the Movement Disorder Society.

[28]  R. Struble,et al.  Apolipoprotein E immunoreactivity in human and mouse olfactory bulb , 1999, Neuroscience Letters.

[29]  S. Nordin,et al.  Perceptual Learning in Olfaction Professional Wine Tasters versus Controls , 1997, Physiology & Behavior.

[30]  R. Dixon,et al.  Selective adult age differences in an age-invariant multifactor model of declarative memory. , 2003, Psychology and aging.

[31]  E. Tulving,et al.  Organization of memory. , 1973 .

[32]  J. Taljaard,et al.  Earlier Age of Onset of Alzheimer's Disease in Patients with Both the Transferrin C2 and Apolipoprotein E‐ɛ4 Alleles , 2000 .

[33]  G. Schellenberg,et al.  Impaired olfaction as a marker for cognitive decline: Interaction with apolipoprotein E 4 status , 1999 .

[34]  Lars-Göran Nilsson,et al.  New frontiers in cognitive aging , 2004 .

[35]  S. Nordin,et al.  Impaired sensory and cognitive olfactory function in questionable Alzheimer's disease. , 1996 .

[36]  S. Nordin,et al.  The Scandinavian Odor-Identification Test: development, reliability, validity and normative data. , 1998, Acta oto-laryngologica.

[37]  Yaakov Stern,et al.  A 10‐item smell identification scale related to risk for Alzheimer's disease , 2005, Annals of neurology.

[38]  D P Salmon,et al.  Apolipoprotein E Status is Associated with Odor Identification Deficits in Nondemented Older Persons a , 1998, Annals of the New York Academy of Sciences.

[39]  P. Switzer,et al.  Delayed olfactory nerve regeneration in ApoE-deficient mice , 2005, Brain Research.

[40]  Lars-Göran Nilsson,et al.  The influence of APOE status on episodic and semantic memory: data from a population-based study. , 2006, Neuropsychology.

[41]  Jonathan D. Smith,et al.  Apolipoproteins and aging: emerging mechanisms , 2002, Ageing Research Reviews.

[42]  Howard Chertkow,et al.  Olfaction in patients with mild cognitive impairment and Alzheimer's disease , 2008, Neurobiology of Aging.

[43]  L. Nyberg,et al.  Betula: A Prospective Cohort Study on Memory, Health and Aging , 2004 .

[44]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[45]  Jonas K. Olofsson,et al.  Odor identification impairment in carriers of ApoE-ɛ4 is independent of clinical dementia , 2010, Neurobiology of Aging.